FBXO32 and dysplastic nevus: Additional analysis of FBXO32 expression in the GSE12391 cohort, containing different stages of the disease, including nevi, dysplastic nevi, primary, and metastatic melanomas, showed that FBXO32 expression was increased in metastatic melanoma as compared to earlier stages (Fig. 1C).